TECH vs XLO · P/E 65, rev $1.22B vs rev $19.1M
Bio-Techne Corp (TECH) versus Xilio Development Inc (XLO) — a side-by-side from cached financials, not a winner call.
Bio-Techne Corp (TECH) is a biotechnology company listed on US.
Xilio Development Inc (XLO) is a biotechnology company listed on NASDAQ.
Latest reported TECH revenue for 2025-06-30 was $1.22B. Net income was $73.4M. Revenue was up 5.2% from 2024-06-30 to 2025-06-30. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
Latest reported XLO revenue for 2025-09-30 was $19.1M. Net income was -$45.4M. XLO currently screens at market cap $55.3M.
TECH currently screens at market cap $8.49B and trailing P/E 65.2. XLO currently screens at market cap $55.3M.
Not investment advice. Open the TECH and XLO stock pages for the full models.
Not investment advice.